Back
Heron Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
HRTX
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
33
HRTX
Heron Therapeutics
Last Price:
3.33
Seasonality Move:
-0.01%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Nvidia?
Go here now for this breaking story.Heron Therapeutics Price Quote
$3.33
+0.29 (+9.36%)
(Updated: June 26, 2024 at 5:25 PM ET)
Heron Therapeutics Key Stats
Sell
33
Heron Therapeutics (HRTX)
is a Sell
Day range:
$3.03 - $3.25
52-week range:
$0.50 - $3.93
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.27
P/B ratio:
0%
Volume:
1.2M
Avg. volume:
2.1M
1-year change:
151.65%
Market cap:
$458.7M
Revenue:
$127M
EPS:
$-0.59
How Much Does Heron Therapeutics Make?
-
How Much Are Heron Therapeutics's Sales Annually?
HRTX Revenues are $127M -
How Much Profit Does Heron Therapeutics's Make A Year?
HRTX net income is -$110.6M
Is Heron Therapeutics Growing As A Company?
-
What Is Heron Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.17% -
What Is Heron Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Heron Therapeutics Stock Price Performance
-
Did Heron Therapeutics Stock Go Up Last Month?
Heron Therapeutics share price went down by -11.48% last month -
Did HRTX's Share Price Rise Over The Last Year?
HRTX share price rose by 151.65% over the past 1 year
What Is Heron Therapeutics 52-Week High & Low?
-
What Is Heron Therapeutics’s 52-Week High Share Price?
Heron Therapeutics has traded as high as $3.93 over the past 52 weeks -
What Is Heron Therapeutics’s 52-Week Low Share Price?
Heron Therapeutics has traded as low as $0.50 over the past 52 weeks
Heron Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Heron Therapeutics?
-
How Much Debt Does Heron Therapeutics Have?
Total long term debt quarterly is $174M -
How Much Cash Does Heron Therapeutics Have?
Cash and short term investments quarterly total is $71.5M -
What Is Heron Therapeutics’s Book Value Per Share?
Book value per share is -0.22
Is Heron Therapeutics Cash Flow Positive?
-
What Is HRTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$43.4M -
What Is Heron Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $54.3M -
What Is Heron Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$17.6M
Heron Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
HRTX return on invested capital is -60.08% -
What Is Heron Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -37.08% -
What Is HRTX Return On Equity?
ROE is a measure of profitability and is 0%
Heron Therapeutics Earnings Date & Stock Price
-
What Is Heron Therapeutics's Stock Price Today?
A single share of HRTX can be purchased today for 3.05 -
What Is Heron Therapeutics’s Stock Symbol?
Heron Therapeutics trades on the nasdaq under the ticker symbol: HRTX -
When Is Heron Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Heron Therapeutics is scheduled on August 14, 2024 -
When Is HRTX's next ex-dividend date?
Heron Therapeutics's next ex-dividend date is May 12, 2020 -
How To Buy Heron Therapeutics Stock?
You can buy Heron Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Heron Therapeutics Competitors
-
Who Are Heron Therapeutics's Competitors?
Below is a list of companies who compete with Heron Therapeutics or are related in some way:
Heron Therapeutics Dividend Yield
Data Unavailable
Heron Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 77.78% |
Revenue: | 17.07% | 5.14% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 6.75 |
Upside from Last Price: | 121.67% |